The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes
Abstract
OBJECTIVE: To determine the rate of metastasis of uveal melanoma on the basis of tumor thickness in millimeters. METHODS: Retrospective medical record review. RESULTS: The mean (median) patient age was 58 (59) years. A total of 8033 eyes were examined. Of the 285 eyes with iris melanoma, the mean tumor thickness was 2.7 mm and metastasis occurred in 0.5%, 4%, and 7% at 3, 5, and 10 years, respectively. Of the 492 eyes with ciliary body melanoma, the mean tumor thickness was 6.6 mm and metastasis occurred in 12%, 19%, and 33% at 3, 5, and 10 years, respectively. Of the 7256 eyes with choroidal melanoma, the mean tumor thickness was 5.5 mm and metastasis occurred in 8%, 15%, and 25% at 3, 5, and 10 years, respectively. For all uveal melanoma, metastasis at 5, 10, and 20 years was 6%, 12%, and 20% for small melanoma (0-3.0 mm thickness), 14%, 26%, and 37% for medium melanoma (3.1-8.0 mm), and 35%, 49%, and 67% for large melanoma (>8.0 mm). More specifically, metastasis per millimeter increment at 10 years was 6% (0-1.0 mm thickness), 12% (1.1-2.0 mm), 12% (2.1-3.0 mm), 16% (3.1-4.0 mm), 27% (4.1-5.0 mm), 28% (5.1-6.0 mm), 29% (6.1-7.0 mm), 41% (7.1-8.0 mm), 50% (8.1-9.0 mm), 44% (9.1-10.0 mm), and 51% (>10.0 mm). Clinical factors predictive of metastasis by multivariate analysis included increasing patient age, ciliary body location, increasing tumor diameter, increasing tumor thickness, having a brown tumor, and the presence of subretinal fluid, intraocular hemorrhage, or extraocular extension. CONCLUSION: Increasing millimeter thickness of uveal melanoma is associated with increasing risk for metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Very Long-Term Prognosis of Patients with Malignant Uveal Melanoma
Kujala, E., Ma¨kitie, T., & Kivela¨, T. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0538 · Cited by 1,045
(2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.7.969 · Cited by 771
Eskelin, S. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00182-2 · Cited by 403
Diener-West, M. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080140101036 · Cited by 355
(1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(98)00039-7 · Cited by 260
Collaborative Ocular Melanoma Study Group (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2004.07.006 · Cited by 259
PROGNOSIS OF MALIGNANT MELANOMAS OF THE CHOROID AND CILIARY BODY
Paul, E. V., Parnell, B. L., & Fraker, M. (1962) · International Ophthalmology Clinics · doi:10.1097/00004397-196206000-00007 · Cited by 219
Routes of Extraocular Extension of Uveal Melanoma
Coupland, S. E., Campbell, I., & Damato, B. E. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.04.025 · Cited by 143
Hoersch, B., Leiter, U., & Garbe, C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07455.x · Cited by 123
Pennie, M. L., Soon, S. L., Risser, J. B., Veledar, E., Culler, S. D., & Chen, S. C. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.4.488 · Cited by 93
Cited by
Jager, M. J., Shields, C. L., Cebulla, C. M., Abdel-Rahman, M. H., Grossniklaus, H. E., Stern, M.-H., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0158-0 · Cited by 825
Self-citationUveal melanoma: relatively rare but deadly cancer
Kaliki, S., & Shields, C. L. (2017) · Eye · doi:10.1038/eye.2016.275 · Cited by 672
Self-citationMetastatic disease from uveal melanoma: treatment options and future prospects
Carvajal, R. D., Schwartz, G. K., Tezel, T., Marr, B., Francis, J. H., & Nathan, P. D. (2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309034 · Cited by 438
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
Dalvin, L. A., Shields, C. L., Orloff, M., Sato, T., & Shields, J. A. (2018) · Retina · doi:10.1097/iae.0000000000002181 · Cited by 336
Self-citationUveal melanoma: Towards a molecular understanding
Smit, K. N., Jager, M. J., de Klein, A., & Kiliҫ, E. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100800 · Cited by 264
Metadata
- Authors
- Shields, C. L.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-08-01
- Volume
- 127
- Issue
- 8
- Pages
- 989
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2107109105
- Cited by
- 626
- References
- 12
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes. https://app.cochat.ai/papers/10.1001/archophthalmol.2009.208
- The paper
- Shields, C. L. (2009). Metastasis of Uveal Melanoma Millimeter-by-Millimeter in 8033 Consecutive Eyes. Archives of Ophthalmology. https://doi.org/10.1001/archophthalmol.2009.208
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.